Summit Global Investments Has $4.81 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Summit Global Investments grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 387.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,026 shares of the company’s stock after acquiring an additional 12,739 shares during the quarter. Summit Global Investments’ holdings in HCA Healthcare were worth $4,810,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. MML Investors Services LLC raised its stake in shares of HCA Healthcare by 31.7% during the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after purchasing an additional 4,285 shares in the last quarter. Meritage Group LP bought a new stake in shares of HCA Healthcare during the 3rd quarter worth approximately $150,548,000. Galvin Gaustad & Stein LLC bought a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $18,044,000. Alpha DNA Investment Management LLC bought a new stake in shares of HCA Healthcare during the 3rd quarter worth approximately $869,000. Finally, NRI Wealth Management LC bought a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $2,896,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

HCA opened at $329.25 on Friday. The firm has a market cap of $81.06 billion, a P/E ratio of 14.99, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The business’s fifty day moving average is $321.50 and its 200-day moving average is $343.43.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the firm earned $5.90 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.87%. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on HCA shares. Morgan Stanley dropped their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price target for the company from $400.00 to $320.00 in a research note on Monday, November 25th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.